Inpatient costs associated with alcohol-associated liver disease (ALD) increased from 2016 to 2019, according to a study in ...

The first oral GLP-1 weight-loss pill, which contains semaglutide, became available nationwide Monday, January 5.

Needle-knife techniques and EUS-RV may be optimal strategies for difficult biliary cannulation in endoscopic retrograde cholangiopancreatography.

Delayed remission with advanced therapies in IBD is not associated with worse 1-year clinical or endoscopic outcomes.

Nutritional issues such as ARFID are highly prevalent among patients with SSc and can lead to poor outcomes and other ...

Researchers evaluated whether pregnancy complications, early childhood characteristics, and tobacco-related exposures were ...

Researchers assessed the risk for serious infection during pregnancy and postpartum based on TNF inhibitor exposure among women with chronic inflammatory disease.

Continuing 5-ASA after escalation to advanced therapy in ulcerative colitis is associated with lower odds of clinical remission.

The Wyoming Supreme Court blocked 2 abortion ban laws that they found to violate a state constitution amendment.

GLP-1RA therapy significantly reduces the risk for new-onset heart failure in patients with type 2 diabetes or obesity, regardless of weight loss.

Ultrasound-derived VAT is more strongly associated with hepatic steatosis and metabolic dysfunction than BMI or waist circumference among adults at risk for MASLD.

The Food and Drug Administration has approved Nereus (tradipitant) for the prevention of vomiting induced by motion in adults.